
News|Articles|October 28, 2024
Quantifying Chemotherapeutic Cytotoxicity in Glial Cells using AI-Driven Label-Free Cell Analysis
Author(s)Sartorius
The response of tumor cells, such as glioblastomas, to cytotoxic chemotherapeutic compounds is a complex and dynamic process that is crucial to understand in neuro-oncology research. Using pre-trained neural networks to accurately segment individual cells and classify them as live or dead is a powerful, robust approach for assessing cytotoxicity in glial cell types.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
2
How Mitigation and Maintenance Protect Against Future Risk
3
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
4
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
5
